April 2004
Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p1046
Academic Journal
Correction notice
Presents an erratum to a Brief Report "Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation," by M. F. Yuen et al. published in a previous issue.


Related Articles

  • High frequency of therapeutic injections, Republic of Moldova.  // Weekly Epidemiological Record;3/19/99, Vol. 74 Issue 11, p84 

    Reports the high frequency of therapeutic injections in Moldova. Association of injections with adverse events; Prevalence of hepatitis B virus infection from administering injections; Attitudes of adults regarding the use of injections to administer medication.

  • CORRECTION: HEPATITIS B VIRUS IN THE UNITED STATES.  // Annals of Internal Medicine;10/4/2011, Vol. 155 Issue 7, p480 

    A correction to a letter to the editor on hepatitis B virus in the U.S. by S. H. Wang, P. Pong, and H. Pollack that was published in the issue 2011 is presented.

  • Hepatitis B Virus Infection – Natural History and Clinical Consequences.  // New England Journal of Medicine;9/16/2004, Vol. 351 Issue 12, p1268 

    A correction to the article �Hepatitis B Virus Infection--Natural History and Clinical Consequences� that was published in the March 11, 2004 issue is presented.

  • A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection. Dienstag, Jules L.; Perrillo, Robert P.; Schiff, Eugene R.; Bartholomew, Maria; Vicary, Catherine; Rubin, Marc // New England Journal of Medicine;12/21/95, Vol. 333 Issue 25, p1657 

    Background: Better treatments for chronic hepatitis B are needed. Lamivudine, the (-)enantiomer of 3'-thiacytidine, is a potent inhibitor of hepatitis B virus (HBV). Methods: In a double-blind trial, we randomly assigned 32 patients with chronic hepatitis B (including 17 who had no response to...

  • Hepatitis B Virus Reactivation in a Patient With Resolved Hepatitis B Virus Infection Receiving Maintenance Rituximab for Malignant B-Cell Lymphoma. Yu Xuan Koo; Tan, Daniel S. W.; Tan, Iain B.; Tao, Miriam; Soon Thye Lim // Annals of Internal Medicine;5/5/2009, Vol. 150 Issue 9, p655 

    A letter is presented concerning a study which aims to report a case of hepatitis B virus (HBV) reactivation in a patient undergoing lymphoma treatment.

  • Cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome. Horikawa, Izumi; Barrett, J. Carl // JNCI: Journal of the National Cancer Institute;8/1/2001, Vol. 93 Issue 15, p1171 

    Examines the cis-activation of the human telomerase gene by the hepatitis B virus genome. Expression of the telomerase in the hepatocellular carcinoma cell line huH-4; Characterization of the hepatitis B virus genome integrated into the promoter region.

  • Dane particle.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p577 

    A definition of the medical term "Dane particle," which refers to hepatitis B virus, is presented.

  • Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Wong, David K.H.; Cheung, Angela M.; O'Rourke, Keith; Naylor, C. David; Detsky, Allan S.; Heathcote, Jenny; Wong, D K; Cheung, A M; O'Rourke, K; Naylor, C D; Detsky, A S; Heathcote, J // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p312 

    Purpose: To determine whether alpha-interferon is effective in terminating viral replication and in eradicating the carrier state in patients with chronic hepatitis B virus (HBV) infection.Data Sources: Randomized controlled studies published in the English literature...

  • Methotrexate withdrawal.  // Reactions Weekly;5/21/2011, Issue 1352, p26 

    The article describes the case of a 41-year-old man who experienced reactivation of hepatitis B virus (HBV) after methotrexate withdrawal.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics